MonoMAC: Difference between revisions
CSV import Tags: mobile edit mobile web edit |
CSV import |
||
| Line 1: | Line 1: | ||
{{Infobox medical condition | |||
| name = MonoMAC | |||
| synonyms = [[Monocytopenia]] with [[Mycobacterial]] and [[Fungal]] [[Infection]]s, [[GATA2 deficiency]] | |||
| specialty = [[Hematology]], [[Immunology]] | |||
| symptoms = [[Monocytopenia]], [[B-cell]] and [[NK cell]] lymphopenia, [[Mycobacterial infection]]s, [[Fungal infection]]s, [[Pulmonary alveolar proteinosis]], [[Lymphedema]], [[Hearing loss]] | |||
| onset = Typically in [[adulthood]] | |||
| duration = [[Chronic]] | |||
| causes = [[Genetic mutation]] in the [[GATA2]] gene | |||
| risks = [[Family history]], [[Genetic predisposition]] | |||
| diagnosis = [[Genetic testing]], [[Blood test]]s showing low [[monocyte]]s, [[B-cell]]s, and [[NK cell]]s | |||
| differential = [[Severe combined immunodeficiency]], [[Chronic granulomatous disease]], [[HIV/AIDS]] | |||
| treatment = [[Hematopoietic stem cell transplantation]], [[Antibiotic]]s, [[Antifungal]]s | |||
| prognosis = Variable, depends on [[treatment]] and [[complications]] | |||
| frequency = Rare | |||
}} | |||
'''MonoMAC''' is a rare hereditary condition that affects the immune system. It is characterized by a decrease in the number of monocytes, a type of white blood cell that helps fight off infections. This condition also affects other types of white blood cells, including neutrophils, B cells, and natural killer cells. MonoMAC can lead to an increased risk of developing severe, recurrent infections. | '''MonoMAC''' is a rare hereditary condition that affects the immune system. It is characterized by a decrease in the number of monocytes, a type of white blood cell that helps fight off infections. This condition also affects other types of white blood cells, including neutrophils, B cells, and natural killer cells. MonoMAC can lead to an increased risk of developing severe, recurrent infections. | ||
== Symptoms == | == Symptoms == | ||
The symptoms of MonoMAC can vary greatly from person to person. Some people may have no symptoms, while others may experience frequent infections, fever, fatigue, and weight loss. In some cases, MonoMAC can lead to the development of myelodysplastic syndrome, a condition that affects the bone marrow's ability to produce blood cells. | The symptoms of MonoMAC can vary greatly from person to person. Some people may have no symptoms, while others may experience frequent infections, fever, fatigue, and weight loss. In some cases, MonoMAC can lead to the development of myelodysplastic syndrome, a condition that affects the bone marrow's ability to produce blood cells. | ||
== Causes == | == Causes == | ||
MonoMAC is caused by mutations in the [[GATA2]] gene. This gene provides instructions for making a protein that plays a crucial role in the development of many cell types, including white blood cells. Mutations in the GATA2 gene disrupt the normal development of these cells, leading to the characteristic features of MonoMAC. | MonoMAC is caused by mutations in the [[GATA2]] gene. This gene provides instructions for making a protein that plays a crucial role in the development of many cell types, including white blood cells. Mutations in the GATA2 gene disrupt the normal development of these cells, leading to the characteristic features of MonoMAC. | ||
== Diagnosis == | == Diagnosis == | ||
Diagnosis of MonoMAC is based on a combination of clinical findings, laboratory tests, and genetic testing. Laboratory tests may show a decrease in the number of monocytes and other white blood cells. Genetic testing can confirm a diagnosis by identifying a mutation in the GATA2 gene. | Diagnosis of MonoMAC is based on a combination of clinical findings, laboratory tests, and genetic testing. Laboratory tests may show a decrease in the number of monocytes and other white blood cells. Genetic testing can confirm a diagnosis by identifying a mutation in the GATA2 gene. | ||
== Treatment == | == Treatment == | ||
Treatment for MonoMAC is aimed at managing symptoms and preventing complications. This may include antibiotics to treat infections, blood transfusions to replace blood cells, and in some cases, a bone marrow transplant. | Treatment for MonoMAC is aimed at managing symptoms and preventing complications. This may include antibiotics to treat infections, blood transfusions to replace blood cells, and in some cases, a bone marrow transplant. | ||
== Prognosis == | == Prognosis == | ||
The prognosis for individuals with MonoMAC can vary. Some people may live relatively normal lives with few complications, while others may experience severe, life-threatening infections. Early diagnosis and treatment can improve the prognosis. | The prognosis for individuals with MonoMAC can vary. Some people may live relatively normal lives with few complications, while others may experience severe, life-threatening infections. Early diagnosis and treatment can improve the prognosis. | ||
== See also == | == See also == | ||
* [[GATA2 deficiency]] | * [[GATA2 deficiency]] | ||
* [[Myelodysplastic syndrome]] | * [[Myelodysplastic syndrome]] | ||
* [[Bone marrow transplant]] | * [[Bone marrow transplant]] | ||
== References == | == References == | ||
<references /> | <references /> | ||
{{stub}} | {{stub}} | ||
[[Category:Rare diseases]] | [[Category:Rare diseases]] | ||
[[Category:Genetic disorders]] | [[Category:Genetic disorders]] | ||
[[Category:Immune system disorders]] | [[Category:Immune system disorders]] | ||
Latest revision as of 00:35, 4 April 2025
| MonoMAC | |
|---|---|
| Synonyms | Monocytopenia with Mycobacterial and Fungal Infections, GATA2 deficiency |
| Pronounce | N/A |
| Specialty | Hematology, Immunology |
| Symptoms | Monocytopenia, B-cell and NK cell lymphopenia, Mycobacterial infections, Fungal infections, Pulmonary alveolar proteinosis, Lymphedema, Hearing loss |
| Complications | N/A |
| Onset | Typically in adulthood |
| Duration | Chronic |
| Types | N/A |
| Causes | Genetic mutation in the GATA2 gene |
| Risks | Family history, Genetic predisposition |
| Diagnosis | Genetic testing, Blood tests showing low monocytes, B-cells, and NK cells |
| Differential diagnosis | Severe combined immunodeficiency, Chronic granulomatous disease, HIV/AIDS |
| Prevention | N/A |
| Treatment | Hematopoietic stem cell transplantation, Antibiotics, Antifungals |
| Medication | N/A |
| Prognosis | Variable, depends on treatment and complications |
| Frequency | Rare |
| Deaths | N/A |
MonoMAC is a rare hereditary condition that affects the immune system. It is characterized by a decrease in the number of monocytes, a type of white blood cell that helps fight off infections. This condition also affects other types of white blood cells, including neutrophils, B cells, and natural killer cells. MonoMAC can lead to an increased risk of developing severe, recurrent infections.
Symptoms[edit]
The symptoms of MonoMAC can vary greatly from person to person. Some people may have no symptoms, while others may experience frequent infections, fever, fatigue, and weight loss. In some cases, MonoMAC can lead to the development of myelodysplastic syndrome, a condition that affects the bone marrow's ability to produce blood cells.
Causes[edit]
MonoMAC is caused by mutations in the GATA2 gene. This gene provides instructions for making a protein that plays a crucial role in the development of many cell types, including white blood cells. Mutations in the GATA2 gene disrupt the normal development of these cells, leading to the characteristic features of MonoMAC.
Diagnosis[edit]
Diagnosis of MonoMAC is based on a combination of clinical findings, laboratory tests, and genetic testing. Laboratory tests may show a decrease in the number of monocytes and other white blood cells. Genetic testing can confirm a diagnosis by identifying a mutation in the GATA2 gene.
Treatment[edit]
Treatment for MonoMAC is aimed at managing symptoms and preventing complications. This may include antibiotics to treat infections, blood transfusions to replace blood cells, and in some cases, a bone marrow transplant.
Prognosis[edit]
The prognosis for individuals with MonoMAC can vary. Some people may live relatively normal lives with few complications, while others may experience severe, life-threatening infections. Early diagnosis and treatment can improve the prognosis.
See also[edit]
References[edit]
<references />
